MUC16 and ovarian carcinoma: The to-date largest screening trial, the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), employing an algorithm incorporating the CA125 profile over time, failed to reduce ovarian cancer mortality (30).